138 related articles for article (PubMed ID: 36634413)
1. A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
Rodríguez Cruz PM; Ravenscroft G; Natera D; Carr A; Manzur A; Liu WW; Vella NR; Jericó I; Gonzalez-Quereda L; Gallano P; Montalto SA; Davis MR; Lamont PJ; Laing NG; Bourque P; Nascimento A; Muntoni F; Polavarapu K; Lochmüller H; Palace J; Beeson D
Neuromuscul Disord; 2023 Feb; 33(2):161-168. PubMed ID: 36634413
[TBL] [Abstract][Full Text] [Related]
2. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
[TBL] [Abstract][Full Text] [Related]
3. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
[TBL] [Abstract][Full Text] [Related]
4. Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report.
Gooneratne IK; Nandasiri S; Maxwell S; Webster R; Cossins J; Beeson D; Gunaratne K; Herath L; Senanayake S; Chang T
J Neuromuscul Dis; 2021; 8(1):163-167. PubMed ID: 33216040
[TBL] [Abstract][Full Text] [Related]
5. End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations.
Croxen R; Young C; Slater C; Haslam S; Brydson M; Vincent A; Beeson D
Brain; 2001 Jul; 124(Pt 7):1362-72. PubMed ID: 11408331
[TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation.
Shen XM; Ohno K; Fukudome T; Tsujino A; Brengman JM; De Vivo DC; Packer RJ; Engel AG
Neurology; 2002 Dec; 59(12):1881-8. PubMed ID: 12499478
[TBL] [Abstract][Full Text] [Related]
7. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.
Rinz CJ; Lennon VA; James F; Thoreson JB; Tsai KL; Starr-Moss AN; Humphries HD; Guo LT; Palmer AC; Clark LA; Shelton GD
Neuromuscul Disord; 2015 Dec; 25(12):921-7. PubMed ID: 26429099
[TBL] [Abstract][Full Text] [Related]
8. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.
Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E
J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513
[TBL] [Abstract][Full Text] [Related]
9. Severe congenital myasthenic syndrome due to homozygosity of the 1293insG epsilon-acetylcholine receptor subunit mutation.
Sieb JP; Kraner S; Schrank B; Reitter B; Goebel TH; Tzartos SJ; Steinlein OK
Ann Neurol; 2000 Sep; 48(3):379-83. PubMed ID: 10976646
[TBL] [Abstract][Full Text] [Related]
10. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
[TBL] [Abstract][Full Text] [Related]
11. Congenital myasthenic syndrome (CMS) in three European kinships due to a novel splice mutation (IVS7 - 2 A/G) in the epsilon acetylcholine receptor (AChR) subunit gene.
Barisic N; Schmidt C; Sidorova OP; Herczegfalvi A; Gekht BM; Song IH; Stucka R; Karcagi V; Abicht A; Lochmüller H
Neuropediatrics; 2002 Oct; 33(5):249-54. PubMed ID: 12536367
[TBL] [Abstract][Full Text] [Related]
12. Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.
Ohno K; Rahman MA; Nazim M; Nasrin F; Lin Y; Takeda JI; Masuda A
J Neurochem; 2017 Aug; 142 Suppl 2():64-72. PubMed ID: 28072465
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
Tei S; Ishii HT; Mitsuhashi H; Ishiura S
Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
[TBL] [Abstract][Full Text] [Related]
14. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.
Sieb JP; Kraner S; Rauch M; Steinlein OK
Hum Genet; 2000 Aug; 107(2):160-4. PubMed ID: 11030414
[TBL] [Abstract][Full Text] [Related]
15. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
16. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.
Dejthevaporn C; Wetchaphanphesat S; Pulkes T; Rattanasiri S; Engel AG; Witoonpanich R
J Clin Neurosci; 2022 Feb; 96():85-89. PubMed ID: 34999496
[TBL] [Abstract][Full Text] [Related]
17. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
[TBL] [Abstract][Full Text] [Related]
18. HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA.
Rahman MA; Masuda A; Ohe K; Ito M; Hutchinson DO; Mayeda A; Engel AG; Ohno K
Sci Rep; 2013 Oct; 3():2931. PubMed ID: 24121633
[TBL] [Abstract][Full Text] [Related]
19. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
Bian Y; Masuda A; Matsuura T; Ito M; Okushin K; Engel AG; Ohno K
Hum Mol Genet; 2009 Apr; 18(7):1229-37. PubMed ID: 19147685
[TBL] [Abstract][Full Text] [Related]
20. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker.
Shen XM; Ohno K; Sine SM; Engel AG
Brain; 2005 Feb; 128(Pt 2):345-55. PubMed ID: 15615813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
